Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | sterol O-acyltransferase 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus granulosus | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma japonicum | ko:K00637 sterol O-acyltransferase [EC2.3.1.26], putative | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma mansoni | sterol O-acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | acyl-CoA:cholesterol acyltransferase alpha ACAT1-alpha | sterol O-acyltransferase 1 | 492 aa | 413 aa | 25.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Protein patched homolog 1 | 0.0402 | 0.1941 | 0.1941 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0977 | 1 | 0.5 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0402 | 0.1941 | 0.1941 |
Giardia lamblia | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.0458 | 0.2728 | 0.5 |
Echinococcus multilocularis | protein dispatched 1 | 0.0402 | 0.1941 | 0.1941 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0402 | 0.1941 | 0.1941 |
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0977 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0977 | 1 | 1 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0977 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0402 | 0.1941 | 0.1941 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0402 | 0.1941 | 0.1941 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0402 | 0.1941 | 0.1941 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.0977 | 1 | 1 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0458 | 0.2728 | 1 |
Schistosoma mansoni | patched 1 | 0.0402 | 0.1941 | 0.1941 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0402 | 0.1941 | 0.1941 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0458 | 0.2728 | 1 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0402 | 0.1941 | 0.1941 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0977 | 1 | 0.5 |
Echinococcus multilocularis | protein patched | 0.0402 | 0.1941 | 0.1941 |
Mycobacterium ulcerans | hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase | 0.0977 | 1 | 0.5 |
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.0977 | 1 | 1 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0458 | 0.2728 | 1 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.0977 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 60 nM | Inhibitory concentration of the compound was evaluated as concentration required to inhibit 50% of the activity of human Acyl coenzyme A:cholesterol acyltransferase 1 | ChEMBL. | 8691472 |
IC50 (binding) | = 60 nM | Inhibitory concentration of the compound was evaluated as concentration required to inhibit 50% of the activity of human Acyl coenzyme A:cholesterol acyltransferase 1 | ChEMBL. | 8691472 |
Plasmaconcentration (functional) | = 1325 nM | Plasma concentration of the compound was measured for every 90 minutes following 10 mg/kg dose in rat. | ChEMBL. | 8691472 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.